Mauna Kea Tech

Paris, France Founded: 2000 • Age: 26 yrs
Endomicroscopy devices are developed for gastrointestinal and respiratory endoscopy.
Request Access

About Mauna Kea Tech

Mauna Kea Tech is a company based in Paris (France) founded in 2000.. Mauna Kea Tech has raised $30 million across 7 funding rounds from investors including European Investment Bank, European Union and Telix Pharmaceuticals. The company has 54 employees as of December 31, 2024. Mauna Kea Tech offers products and services including Cellvizio Platform and Confocal Miniprobes. Mauna Kea Tech operates in a competitive market with competitors including EchoSens, CapsoVision, Smart Medical Systems, Invendo Medical and GI View, among others.

  • Headquarter Paris, France
  • Employees 54 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Mauna Kea Technologies Sa Class O
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $7.96 M (USD)
    -26.96
    as on Dec 31, 2024
  • Net Profit
    $-10.8 M (USD)
    -179.15
    as on Dec 31, 2024
  • EBITDA
    $-5.23 M (USD)
    -11.33
    as on Dec 31, 2024
  • Total Equity Funding
    $30 M (USD)

    in 7 rounds

  • Latest Funding Round
    $6.41 M (USD), Post-IPO

    Nov 13, 2023

  • Investors
  • Employee Count
    54

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Mauna Kea Tech

Mauna Kea Tech is a publicly listed company on the EURONEXT with ticker symbol ALMKT in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: EURONEXT · Ticker: ALMKT . Sector: Health technology · France

Products & Services of Mauna Kea Tech

Mauna Kea Tech offers a comprehensive portfolio of products and services, including Cellvizio Platform and Confocal Miniprobes. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Offers real-time in vivo cellular imaging for disease diagnosis and treatment.

Tools for inserting into endoscopes to enable cellular visualization.

People of Mauna Kea Tech
Headcount 50-200
Employee Profiles 28
Board Members and Advisors 4
Employee Profiles
People
Conor Smith
Territory Manager
People
François Lacombe
Chief Scientific Officer
People
Bruno Villaret
VP, International Sales
People
Frédéric Banégas
CTO

Unlock access to complete

Board Members and Advisors
people
Christopher D. McFadden
Member of the Board
people
Claire Biot
Member of the Board
people
Molly O'Neill
Member of the Board
people
Jacquelien Ten Dam
Member of the board

Unlock access to complete

Funding Insights of Mauna Kea Tech

Mauna Kea Tech has successfully raised a total of $30M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $6.41 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Post-IPO — $6.4M
  • First Round

    (23 Jan 2008)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2023 Amount Post-IPO - Mauna Kea Tech Valuation

investors

Dec, 2019 Amount Post-IPO - Mauna Kea Tech Valuation

investors

Jul, 2019 Amount Debt – Conventional - Mauna Kea Tech Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Mauna Kea Tech

Mauna Kea Tech has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include European Investment Bank, European Union and Telix Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Finance and advisory services for infrastructure projects are provided.
Founded Year Domain Location
Alternative financing is provided by IPF Partners for healthcare.
Founded Year Domain Location
Tech and offline sectors are invested in globally by Creadev.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Mauna Kea Tech

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Mauna Kea Tech

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Mauna Kea Tech Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Mauna Kea Tech

Mauna Kea Tech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EchoSens, CapsoVision, Smart Medical Systems, Invendo Medical and GI View, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Non-invasive diagnostics for liver disease detection are developed.
domain founded_year HQ Location
GI capsule endoscopy systems are developed for intestinal imaging.
domain founded_year HQ Location
Endoscopes and devices for GI diagnosis and treatment are produced.
domain founded_year HQ Location
Sterile single-use robotics-based endoscopes are developed for gastroenterology.
domain founded_year HQ Location
Devices for GI disorder diagnosis and treatment are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Mauna Kea Tech

Frequently Asked Questions about Mauna Kea Tech

When was Mauna Kea Tech founded?

Mauna Kea Tech was founded in 2000 and raised its 1st funding round 8 years after it was founded.

Where is Mauna Kea Tech located?

Mauna Kea Tech is headquartered in Paris, France.

Is Mauna Kea Tech a funded company?

Mauna Kea Tech is a funded company, having raised a total of $30M across 7 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $12.89M, raised on Jan 23, 2008.

How many employees does Mauna Kea Tech have?

As of Dec 31, 2024, the latest employee count at Mauna Kea Tech is 54.

What is the annual revenue of Mauna Kea Tech?

Annual revenue of Mauna Kea Tech is $7.96M as on Dec 31, 2024.

What does Mauna Kea Tech do?

Mauna Kea Technologies produces devices for microscopic imaging during endoscopy procedures. Its tools allow surgeons to visualize, take biopsies, detect or rule out malignant or pre-malignant tumors or lesions in the gastrointestinal tract and pulmonary tracts. Their flagship product, Cellvizio, is a probe-based Confocal Laser Endomicroscopy (pCLE) system, that provides real-time access to histological images during standard endoscopy procedures through high-resolution cellular imaging of internal tissues. Cellvizio is cleared by FDA and has the European CE-Mark for use during digestive, pulmonary and urinary endoscopy procedures, including pancreatic and biliary endoscopic explorations as well as fine needle aspiration procedures. Mauna Kea Technologies also obtained clearance in China and Japan. Cellvizio went public in July 2011 and trades on the NYSE Euronext exchange.

Who are the top competitors of Mauna Kea Tech?

Mauna Kea Tech's top competitors include EchoSens, CapsoVision and Invendo Medical.

What products or services does Mauna Kea Tech offer?

Mauna Kea Tech offers Cellvizio Platform and Confocal Miniprobes.

Is Mauna Kea Tech publicly traded?

Yes, Mauna Kea Tech is publicly traded on EURONEXT under the ticker symbol ALMKT.

Who are Mauna Kea Tech's investors?

Mauna Kea Tech has 7 investors. Key investors include European Investment Bank, European Union, Telix Pharmaceuticals, Johnson & Johnson Innovation, and IPF Partners.

What is Mauna Kea Tech's ticker symbol?

The ticker symbol of Mauna Kea Tech is ALMKT on EURONEXT.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available